IE38681B1 - Imidazotriazines - Google Patents
ImidazotriazinesInfo
- Publication number
- IE38681B1 IE38681B1 IE2345/73A IE234573A IE38681B1 IE 38681 B1 IE38681 B1 IE 38681B1 IE 2345/73 A IE2345/73 A IE 2345/73A IE 234573 A IE234573 A IE 234573A IE 38681 B1 IE38681 B1 IE 38681B1
- Authority
- IE
- Ireland
- Prior art keywords
- hydrogen atom
- alkyl
- group
- aralkyl
- aryl
- Prior art date
Links
- XZLIYCQRASOFQM-UHFFFAOYSA-N 5h-imidazo[4,5-d]triazine Chemical class N1=NC=C2NC=NC2=N1 XZLIYCQRASOFQM-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 abstract 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000003435 aroyl group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 230000003177 cardiotonic effect Effects 0.000 abstract 1
- 239000000812 cholinergic antagonist Substances 0.000 abstract 1
- 230000001882 diuretic effect Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- CFHPLGYSONYRLK-UHFFFAOYSA-N imidazo[5,1-f][1,2,4]triazin-2-amine Chemical compound N1=C(N)N=CC2=CN=CN21 CFHPLGYSONYRLK-UHFFFAOYSA-N 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229960001317 isoprenaline Drugs 0.000 abstract 1
- 238000005935 nucleophilic addition reaction Methods 0.000 abstract 1
- 239000008024 pharmaceutical diluent Substances 0.000 abstract 1
- 229960002052 salbutamol Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000002048 spasmolytic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB55373*[A GB1457873A (en) | 1973-01-04 | 1973-01-04 | Imidazotriazines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE38681L IE38681L (en) | 1974-07-04 |
| IE38681B1 true IE38681B1 (en) | 1978-05-10 |
Family
ID=9706420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2345/73A IE38681B1 (en) | 1973-01-04 | 1973-12-31 | Imidazotriazines |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US3941785A (en, 2012) |
| JP (1) | JPS4995994A (en, 2012) |
| AT (1) | AT336029B (en, 2012) |
| AU (1) | AU474078B2 (en, 2012) |
| BE (1) | BE809369A (en, 2012) |
| CA (1) | CA1005057A (en, 2012) |
| CH (1) | CH618170A5 (en, 2012) |
| DE (1) | DE2364076A1 (en, 2012) |
| ES (1) | ES422001A1 (en, 2012) |
| FI (2) | FI57260C (en, 2012) |
| FR (1) | FR2213058B1 (en, 2012) |
| GB (1) | GB1457873A (en, 2012) |
| IE (1) | IE38681B1 (en, 2012) |
| IL (1) | IL43872A (en, 2012) |
| LU (1) | LU69099A1 (en, 2012) |
| NL (1) | NL7400095A (en, 2012) |
| NO (1) | NO140301C (en, 2012) |
| SE (1) | SE408179B (en, 2012) |
| ZA (1) | ZA739534B (en, 2012) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK109578A (da) * | 1977-03-25 | 1978-09-26 | Allen & Hanburys Ltd | Fremgangsmaade til fremstilling af heterocycliske forbindelser |
| US4107309A (en) * | 1977-05-23 | 1978-08-15 | American Cyanamid Company | Substituted imidazo[1,2-d]-as-triazines |
| US4096257A (en) * | 1977-05-23 | 1978-06-20 | American Cyanamid Company | Substituted imidazo [1,2-d]-as-triazines |
| US4126444A (en) * | 1977-11-22 | 1978-11-21 | American Cynamid Company | Substituted imidazo (1,5-D)-as-triazin-4-ols, and herbicidal use thereof |
| US4308384A (en) * | 1978-09-18 | 1981-12-29 | Glaxo Group Limited | Production of triazinones |
| DD244681A3 (de) * | 1985-12-02 | 1987-04-15 | Zeiss Jena Veb Carl | Vorrichtung zur positionierung von enden flexibler lichtleitelemente |
| US6624181B1 (en) * | 1997-02-28 | 2003-09-23 | Altana Pharma Ag | Synergistic combination |
| WO1999024433A1 (de) * | 1997-11-12 | 1999-05-20 | Bayer Aktiengesellschaft | 2-phenyl-substituierte imidazotriazinone als phosphodiesterase inhibitoren |
| DE19827640A1 (de) * | 1998-06-20 | 1999-12-23 | Bayer Ag | 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone |
| AU754379B2 (en) | 1998-08-26 | 2002-11-14 | Smithkline Beecham Corporation | Therapies for treating pulmonary diseases |
| ES2260043T3 (es) * | 1999-08-21 | 2006-11-01 | Altana Pharma Ag | Combinacion sinergica de roflumilast y salmeterol. |
| PL363679A1 (en) * | 2001-05-09 | 2004-11-29 | Bayer Healthcare Ag | Novel use of 2-phenyl-substituted imidazotriazinones |
| GB0113343D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel Heterocycles 2 |
| GB0113344D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel heterocycles 3 |
| DE10130167A1 (de) * | 2001-06-22 | 2003-01-02 | Bayer Ag | Imidazotriazine |
| DE10135815A1 (de) | 2001-07-23 | 2003-02-06 | Bayer Ag | Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen |
| DE10230605A1 (de) * | 2002-07-08 | 2004-01-29 | Bayer Ag | Substituierte Imidazotriazine |
| DE10230604A1 (de) * | 2002-07-08 | 2004-01-29 | Bayer Ag | Heterocyclisch substituierte Imidazotriazine |
| DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
| EP1608656B1 (en) * | 2003-04-01 | 2009-06-03 | SmithKline Beecham Corporation | Imidazotriazine compounds for the treatment of cancer diseases |
| DE102005001989A1 (de) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenöse Formulierungen von PDE-Inhibitoren |
| DE102005009240A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
| DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
| US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| JP2009509984A (ja) * | 2005-09-29 | 2009-03-12 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 泌尿器系障害の処置用のｐｄｅ阻害剤およびそれらの組合せ |
| US7985756B2 (en) | 2005-10-21 | 2011-07-26 | Braincells Inc. | Modulation of neurogenesis by PDE inhibition |
| CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US20070244143A1 (en) * | 2006-03-08 | 2007-10-18 | Braincells, Inc | Modulation of neurogenesis by nootropic agents |
| WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| WO2007134136A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| KR20090064418A (ko) * | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
| EP2066355A2 (en) * | 2006-09-19 | 2009-06-10 | Braincells, Inc. | Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| JP2010532319A (ja) * | 2007-06-13 | 2010-10-07 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | 聴覚障害の処置用のｐｄｅ阻害剤 |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE791025A (fr) * | 1971-11-19 | 1973-05-07 | Allen & Hanburys Ltd | Composes heterocycliques |
-
1973
- 1973-01-04 GB GB55373*[A patent/GB1457873A/en not_active Expired
- 1973-12-18 FI FI3900/73A patent/FI57260C/fi active
- 1973-12-18 ZA ZA739534A patent/ZA739534B/xx unknown
- 1973-12-18 NO NO4843/73A patent/NO140301C/no unknown
- 1973-12-19 AU AU63774/73A patent/AU474078B2/en not_active Expired
- 1973-12-20 IL IL43872A patent/IL43872A/xx unknown
- 1973-12-21 DE DE2364076A patent/DE2364076A1/de not_active Withdrawn
- 1973-12-26 US US05/427,558 patent/US3941785A/en not_active Expired - Lifetime
- 1973-12-28 CA CA189,199A patent/CA1005057A/en not_active Expired
- 1973-12-28 FR FR7346979A patent/FR2213058B1/fr not_active Expired
- 1973-12-31 JP JP49004782A patent/JPS4995994A/ja active Pending
- 1973-12-31 IE IE2345/73A patent/IE38681B1/xx unknown
-
1974
- 1974-01-02 LU LU69099A patent/LU69099A1/xx unknown
- 1974-01-02 AT AT2374A patent/AT336029B/de not_active IP Right Cessation
- 1974-01-02 CH CH9274A patent/CH618170A5/de not_active IP Right Cessation
- 1974-01-03 SE SE7400062A patent/SE408179B/xx unknown
- 1974-01-03 ES ES422001A patent/ES422001A1/es not_active Expired
- 1974-01-03 BE BE139496A patent/BE809369A/xx unknown
- 1974-01-04 NL NL7400095A patent/NL7400095A/xx not_active Application Discontinuation
-
1979
- 1979-10-10 FI FI793137A patent/FI793137A7/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US3941785A (en) | 1976-03-02 |
| IL43872A0 (en) | 1974-03-14 |
| CA1005057A (en) | 1977-02-08 |
| IL43872A (en) | 1979-01-31 |
| NO140301B (no) | 1979-04-30 |
| IE38681L (en) | 1974-07-04 |
| FR2213058A1 (en, 2012) | 1974-08-02 |
| ZA739534B (en) | 1974-11-27 |
| AU6377473A (en) | 1975-06-19 |
| AT336029B (de) | 1977-04-12 |
| NO140301C (no) | 1979-08-08 |
| ES422001A1 (es) | 1976-08-01 |
| ATA2374A (de) | 1976-08-15 |
| FR2213058B1 (en, 2012) | 1977-07-01 |
| CH618170A5 (en, 2012) | 1980-07-15 |
| FI57260C (fi) | 1980-07-10 |
| DE2364076A1 (de) | 1974-07-18 |
| SE408179B (sv) | 1979-05-21 |
| NL7400095A (en, 2012) | 1974-07-08 |
| FI793137A7 (fi) | 1981-01-01 |
| LU69099A1 (en, 2012) | 1974-04-02 |
| BE809369A (fr) | 1974-07-03 |
| FI57260B (fi) | 1980-03-31 |
| AU474078B2 (en) | 1976-07-15 |
| JPS4995994A (en, 2012) | 1974-09-11 |
| GB1457873A (en) | 1976-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE38681B1 (en) | Imidazotriazines | |
| GB1535770A (en) | Pharmaceutical compositions | |
| GB1292601A (en) | Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them | |
| GB1528723A (en) | 1-nitro-9-n-substituted aminoalkylamino-acridines their salts and a method of preparing same | |
| GB1507118A (en) | Antibiotic derivatives of 3',4'-dideoxykanamycin b and the preparation thereof | |
| IE33371B1 (en) | Protozoacidally-active substituted guanidines | |
| GB1409648A (en) | Substituted pyrrolidinemethanol compounds and pharmaceutical compositions thereof | |
| GB1322451A (en) | 3-amino-5-benzyl-1,2,4-oxadiazoles | |
| GB1131164A (en) | Novel halogen-substituted tetrahydroquinazoline derivatives, their preparation and compositions containing them | |
| IE40893L (en) | PYRIMIDO [1,2-a] QUINOLINES | |
| GB1174880A (en) | Derivatives of alpha-Piperazinophenylacetonitrile and process for manufacture of same | |
| GB1053301A (en, 2012) | ||
| GB1416421A (en) | 1,4-dihydro-3 2h- isoquinolinone derivatives and preparation thereof | |
| GB1306511A (en) | Imidazoline derivatives | |
| GB1276719A (en) | Benzomorphan derivatives and their salts | |
| GB1212111A (en) | New salicylamides | |
| GB1154494A (en) | Novel N-Cycloalkyl-Azabicyclooctanes and Nonanes and Novel Intermediates and process for preparation | |
| GB1245155A (en) | NOVEL 5-SUBSTITUTED-gamma-CARBOLINE DERIVATIVES AND THE SALTS THEREOF | |
| IE33283L (en) | N-arallyl-n'aralkyl piperazines | |
| GB1346456A (en) | Organic acid 2,6-disubstituted phenyl hydrazides | |
| GB1168939A (en) | Improvements in or relating to Sulphamides and the manufacture thereof | |
| GB1164058A (en) | Novel Sulphanilamides and a process for the manufacture thereof | |
| GB1329447A (en) | 4-adamantylaminoalkylamino-2-styryl-quinolines salts and derivatives thereof | |
| GB1433977A (en) | Acyl derivatives | |
| GB1434099A (en) | 1,3-diazocine derivatives |